Literature DB >> 17491063

Hematopoietic growth factors: ESMO recommendations for the application.

R Greil, O Psenak.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17491063     DOI： 10.1093/annonc/mdm052

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

1.  Incidence of febrile neutropenia during adjuvant chemotherapy for breast cancer: a prospective study.

Authors:  D Rayson; S Lutes; M Sellon; B Colwell; M Dorreen; A Drucker; A Jeyakumar; S Snow; T Younis
Journal:  Curr Oncol       Date:  2012-06       Impact factor: 3.677

2.  Model-based prediction of myelosuppression and recovery based on frequent neutrophil monitoring.

Authors:  Ida Netterberg; Elisabet I Nielsen; Lena E Friberg; Mats O Karlsson
Journal:  Cancer Chemother Pharmacol       Date:  2017-06-27       Impact factor: 3.333

3.  Effectiveness of cytopenia prophylaxis for different filgrastim and pegfilgrastim schedules in a chemotherapy mouse model.

Authors:  Markus Scholz; Manuela Ackermann; Frank Emmrich; Markus Loeffler; Manja Kamprad
Journal:  Biologics       Date:  2009-07-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.